Pacific Edge Limited (PFGTF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -45.91 Million NZD | -33.43% |
| 2023 | -34.41 Million NZD | -36.06% |
| 2022 | -15.38 Million NZD | -29.84% |
| 2021 | -11.85 Million NZD | -1.54% |
| 2020 | -11.67 Million NZD | 39.28% |
| 2019 | -19.22 Million USD | 9.53% |
| 2018 | -21.24 Million USD | 11.69% |
| 2017 | -24.05 Million USD | -93.65% |
| 2016 | -12.42 Million USD | -25.02% |
| 2015 | -9.93 Million NZD | -19.06% |
| 2014 | -8.34 Million NZD | -65.69% |
| 2013 | -5.03 Million NZD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -5.48 Million USD | 50.47% |
| 2024 Q2 | -5.35 Million USD | -109.25% |
| 2024 FY | -34.9 Million NZD | -66.7% |
| 2024 Q4 | -6.54 Million USD | -39.29% |
| 2024 Q3 | -4.96 Million USD | 57.98% |
| 2023 FY | -20.93 Million NZD | -36.06% |
| 2023 Q4 | -5.42 Million USD | 1.5% |
| 2023 Q3 | -5.51 Million USD | -34.09% |
| 2023 Q2 | -4.11 Million USD | 0.0% |
| 2022 FY | -15.38 Million NZD | -29.84% |
| 2022 Q2 | -7.08 Million USD | 0.0% |
| 2022 Q4 | -8.26 Million USD | 0.0% |
| 2021 Q2 | -5.14 Million USD | 0.0% |
| 2021 FY | -11.85 Million NZD | -1.54% |
| 2021 Q4 | -6.39 Million USD | 0.0% |
| 2020 Q2 | -6.14 Million USD | 0.0% |
| 2020 Q4 | -5.87 Million USD | 0.0% |
| 2020 FY | -11.67 Million NZD | 39.28% |
| 2019 FY | -19.22 Million USD | 9.53% |
| 2018 FY | -21.24 Million USD | 11.69% |
| 2017 FY | -24.05 Million USD | -93.65% |
| 2016 FY | -12.42 Million USD | -25.02% |
| 2015 FY | -9.93 Million NZD | -19.06% |
| 2014 FY | -8.34 Million NZD | -65.69% |
| 2013 FY | -5.03 Million NZD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -3597.021% |
| Arrayit Corporation | -3.62 Million USD | -1167.544% |
| Atlantic International Corp. | -5.73 Million USD | -700.993% |
| Biocept, Inc. | -31.98 Million USD | -43.567% |
| Bioqual, Inc. | -19.63 Thousand USD | -233717.089% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -5846.704% |
| DermTech, Inc. | -103.73 Million USD | 55.738% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 101.846% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | -120.441% |
| iMD Companies, Inc. | -175.44 Thousand USD | -26071.586% |
| IDenta Corp. | -1499.00 USD | -3063075.45% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 1737.553% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 118779.245% |
| InVitro International | -25.33 Thousand USD | -181110.782% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | -544.721% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -78914.661% |
| Medical Imaging Corp. | -819.48 Thousand USD | -5503.187% |
| NovelStem International Corp. | -3.52 Million USD | -1202.315% |
| Optigenex Inc. | 1.39 Million USD | 3401.398% |
| PharmChem, Inc. | 973.14 Thousand USD | 4818.403% |
| Proteome Sciences plc | -1.62 Million USD | -2732.634% |
| Response Genetics, Inc | -21.37 Million USD | -114.796% |
| Rennova Health, Inc. | -1.4 Million USD | -3157.601% |
| RushNet, Inc. | -684.7 Thousand USD | -6606.1% |
| ScreenPro Security Inc. | -2.59 Million USD | -1671.197% |
| Stella Diagnostics Inc. | -11.42 Million USD | -301.831% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | -492.725% |
| Todos Medical Ltd. | -9.74 Million USD | -371.04% |